Literature DB >> 18684945

CD46-induced immunomodulatory CD4+ T cells express the adhesion molecule and chemokine receptor pattern of intestinal T cells.

Shannon K Alford1, Gregory D Longmore, William F Stenson, Claudia Kemper.   

Abstract

Tissue homing of activated T cells is typically mediated through their specific integrin and chemokine receptor repertoire. Activation of human primary CD4(+) T cells in the presence of CD46 cross-linking induces the development of a distinct immunomodulatory T cell population characterized by high IL-10/granzyme B production. How these regulatory T cells (Tregs) migrate/home to specific tissue sites is not understood. In this study, we determined the adhesion protein and chemokine receptor expression pattern on human CD3/CD46-activated peripheral blood CD4(+) T cells. CD3/CD46-activated, but not CD3/CD28-activated, T cells up-regulate the integrin alpha(4)beta(7). The interaction of alpha(4)beta(7) with its ligand mucosal addressin cell adhesion molecule 1 (MAdCAM-1) mediates homing or retention of T cells to the intestine. CD3/CD46-activated Tregs adhere to/roll on MAdCAM-1-expressing HeLa cells, similar to T cells isolated from the human lamina propria (LP). This interaction is inhibited by silencing MAdCAM-1 expression in HeLa cells or by the addition of blocking Abs to beta(7). CD46 activation of T cells also induced the expression of the surface-bound cytokine LIGHT and the chemokine receptor CCR9, both marker constitutively expressed by gut LP-resident T cells. In addition, we found that approximately 10% of the CD4(+) T lymphocytes isolated from the LP of patients undergoing bariatric surgery contain T cells that spontaneously secrete a cytokine pattern consistent with that from CD46-activated T cells. These data suggest that CD46-induced Tregs might play a role in intestinal immune homeostasis where they could dampen unwanted effector T cell responses through local IL-10/granzyme B production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18684945      PMCID: PMC2597161          DOI: 10.4049/jimmunol.181.4.2544

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

Review 1.  Regulatory T cells: key controllers of immunologic self-tolerance.

Authors:  S Sakaguchi
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

2.  CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase.

Authors:  Y Zaffran; O Destaing; A Roux; S Ory; T Nheu; P Jurdic; C Rabourdin-Combe; A L Astier
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

3.  Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity.

Authors:  Philippe Stock; Omid Akbari; Gerald Berry; Gordon J Freeman; Rosemarie H Dekruyff; Dale T Umetsu
Journal:  Nat Immunol       Date:  2004-09-26       Impact factor: 25.606

4.  The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system.

Authors:  K A Papadakis; J Prehn; V Nelson; L Cheng; S W Binder; P D Ponath; D P Andrew; S R Targan
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

5.  Dissecting sites important for complement regulatory activity in membrane cofactor protein (MCP; CD46).

Authors:  M K Liszewski; M Leung; W Cui; V B Subramanian; J Parkinson; P N Barlow; M Manchester; J P Atkinson
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

6.  Retinoic acid imprints gut-homing specificity on T cells.

Authors:  Makoto Iwata; Asami Hirakiyama; Yuko Eshima; Hiroyuki Kagechika; Chieko Kato; Si-Young Song
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

7.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death.

Authors:  William J Grossman; James W Verbsky; Winfried Barchet; Marco Colonna; John P Atkinson; Timothy J Ley
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

Review 8.  CD46: expanding beyond complement regulation.

Authors:  Rebecca C Riley-Vargas; Darcy B Gill; Claudia Kemper; M Kathryn Liszewski; John P Atkinson
Journal:  Trends Immunol       Date:  2004-09       Impact factor: 16.687

9.  CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa.

Authors:  Marcus Svensson; Jan Marsal; Anna Ericsson; Laura Carramolino; Therese Brodén; Gabriel Márquez; William W Agace
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 10.  Type 1 T regulatory cells.

Authors:  M G Roncarolo; R Bacchetta; C Bordignon; S Narula; M K Levings
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

View more
  13 in total

1.  CD46 engagement on human CD4+ T cells produces T regulatory type 1-like regulation of antimycobacterial T cell responses.

Authors:  Steven M Truscott; Getahun Abate; Jeffrey D Price; Claudia Kemper; John P Atkinson; Daniel F Hoft
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios.

Authors:  Jörn-Hendrik Weitkamp; Tatsuki Koyama; Michael T Rock; Hernan Correa; Jeremy A Goettel; Pranathi Matta; Kyra Oswald-Richter; Michael J Rosen; Brian G Engelhardt; Daniel J Moore; D Brent Polk
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

Review 3.  CD46 in innate and adaptive immunity: an update.

Authors:  J Cardone; G Le Friec; C Kemper
Journal:  Clin Exp Immunol       Date:  2011-04-13       Impact factor: 4.330

Review 4.  CD46 processing: a means of expression.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Immunobiology       Date:  2011-07-13       Impact factor: 3.144

Review 5.  CD46 plasticity and its inflammatory bias in multiple sclerosis.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2011-01-26       Impact factor: 4.291

6.  Combinatorial effects of interleukin 10 and interleukin 4 determine the progression of hepatic inflammation following murine enteric parasitic infection.

Authors:  Diana B Douglas; Daniel P Beiting; John P Loftus; Judith A Appleton; Susan K Bliss
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

7.  Mechanism of neuroinflammation: enhanced cytotoxicity and IL-17 production via CD46 binding.

Authors:  Karen Yao; Jhanelle Graham; Yoshimi Akahata; Unsong Oh; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-07-27       Impact factor: 4.147

8.  CD46-induced human Treg enhance B-cell responses.

Authors:  Anja Fuchs; John P Atkinson; Veronique Fremeaux-Bacchi; Claudia Kemper
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

9.  Diapedesis-Induced Integrin Signaling via LFA-1 Facilitates Tissue Immunity by Inducing Intrinsic Complement C3 Expression in Immune Cells.

Authors:  Martin Kolev; Erin E West; Natalia Kunz; Daniel Chauss; E Ashley Moseman; Jubayer Rahman; Tilo Freiwald; Maria L Balmer; Jonas Lötscher; Sarah Dimeloe; Elizabeth C Rosser; Lucy R Wedderburn; Katrin D Mayer-Barber; Andrea Bohrer; Paul Lavender; Andrew Cope; Luopin Wang; Mariana J Kaplan; Niki M Moutsopoulos; Dorian McGavern; Steven M Holland; Christoph Hess; Majid Kazemian; Behdad Afzali; Claudia Kemper
Journal:  Immunity       Date:  2020-03-17       Impact factor: 31.745

10.  The CD46-Jagged1 interaction is critical for human TH1 immunity.

Authors:  Gaëlle Le Friec; Devon Sheppard; Pat Whiteman; Christian M Karsten; Salley Al-Tilib Shamoun; Adam Laing; Laurence Bugeon; Margaret J Dallman; Teresa Melchionna; Chandramouli Chillakuri; Richard A Smith; Christian Drouet; Lionel Couzi; Veronique Fremeaux-Bacchi; Jörg Köhl; Simon N Waddington; James M McDonnell; Alastair Baker; Penny A Handford; Susan M Lea; Claudia Kemper
Journal:  Nat Immunol       Date:  2012-10-21       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.